Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Economou

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
NK and CD4 cells collaborate to protect against melanoma tumor formation in the brainRobert M Prins, Dan D Vo, Haumith Khan-Farooqi, et al.
Journal of the National Cancer Institute|April 19, 1995
Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7S M Dubinett, M Huang, S Dhanani, et al.
Journal of Telemedicine and Telecare|October 27, 1999
Telemedicine on a small islandR Balestri, E Cavina, A Aliferis, et al.
Immunological Investigations|February 1, 1993
Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapyS M Dubinett, L Patrone, M Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cellsYu-Pei Liao, Chun-Chieh Wang, Lisa H Butterfield, et al.
Molecular Immunology|June 8, 2001
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoproteinW S Meng, L H Butterfield, A Ribas, et al.
Journal of Translational Medicine|June 21, 2012
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapyJon G Quatromoni, Yue Wang, Dan D Vo, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1992
Technical details of intraoperative lymphatic mapping for early stage melanomaD L Morton, D R Wen, J H Wong, et al.
Human Gene Therapy|February 4, 1998
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2L A Bui, L H Butterfield, J Y Kim, et al.
Cancer Gene Therapy|January 1, 1996
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vectorE M Toloza, K Hunt, S Swisher, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
NK and CD4 cells collaborate to protect against melanoma tumor formation in the brainRobert M Prins, Dan D Vo, Haumith Khan-Farooqi, et al.
Journal of the National Cancer Institute|April 19, 1995
Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7S M Dubinett, M Huang, S Dhanani, et al.
Journal of Telemedicine and Telecare|October 27, 1999
Telemedicine on a small islandR Balestri, E Cavina, A Aliferis, et al.
Immunological Investigations|February 1, 1993
Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapyS M Dubinett, L Patrone, M Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cellsYu-Pei Liao, Chun-Chieh Wang, Lisa H Butterfield, et al.
Molecular Immunology|June 8, 2001
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoproteinW S Meng, L H Butterfield, A Ribas, et al.
Journal of Translational Medicine|June 21, 2012
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapyJon G Quatromoni, Yue Wang, Dan D Vo, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1992
Technical details of intraoperative lymphatic mapping for early stage melanomaD L Morton, D R Wen, J H Wong, et al.
Human Gene Therapy|February 4, 1998
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2L A Bui, L H Butterfield, J Y Kim, et al.
Cancer Gene Therapy|January 1, 1996
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vectorE M Toloza, K Hunt, S Swisher, et al.
Pageof 16